Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease



Some epidemiological studies found a lower risk of cardiovascular disease among wine drinkers than among drinkers of other types of ethanol. This difference might be due to an effect of nonalcohol compounds in wine on important cardiovascular risk factors. The objective of this study was to compare the effect of red wine, nonalcohol compounds of red wine and placebo on established cardiovascular risk factors.


A parallel, four-armed intervention study.


A total of 69 healthy 38–74-y-old men and women.


Subjects were randomised to either 1: red wine (males: 300 ml/day, 38.3 g alcohol/day, female subjects: 200 ml/day, 25.5 g alcohol/day), 2: water+red grape extract tablets (wine-equivalent dose), 3: water+red grape extract tablets (half dose), or 4: water+placebo tablets for a period of 4 weeks. No other sources of alcohol or anthocyanin were allowed. Plasma high-density lipoprotein (HDL)-cholesterol (HDL-C), low-density lipoprotein (LDL)-cholesterol (LDL-C), HDL-C/LDL-C-ratio, very-low-density lipoprotein (VLDL)-triacylglycerol, total cholesterol, fibrinogen, factor VII coagulant activity (FVIIc), blood pressure, and body weight were determined before and after intervention.


Wine consumption was associated with a significant 11–16% increase in fasting HDL-C and 8–15% decrease in fasting fibrinogen relative to not drinking wine. There were no significant treatment effects on fasting LDL-C, HDL-C/LDL-C-ratio, VLDL-triacylglycerol, total cholesterol, FVIIc, or blood pressure. Drinking wine was associated with relative body weight increments closely corresponding to the energy contributed by the alcohol component.


Moderate red wine consumption for 4 weeks is associated with desirable changes in HDL-C and fibrinogen compared with drinking water with or without red grape extract. The impact of wine on the measured cardiovascular risk factors thus seems primarily explained by an alcohol effect. Our finding suggests that the putative difference in cardiac risk associated with wine vs other alcoholic beverages might be rather explained by other life-style confounders than by red wine contents of nonalcohol components.


This study was supported by Chr. Hansen A/S, Denmark.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout


  • Baumstark MW, Kreutz W, Berg A, Frey I & Keul J (1991): Structure of human low-density lipoprotein subfractions, determined by X-ray small angle scattering. Biochem. Biophys. Acta 1037, 48–57.

    Google Scholar 

  • Bell JRC, Donovan JL, Donovan JL, Wong R, Waterhouse AL, German JB & Kasim-Karakas SE (2000): (+)-Catechin in plasma after ingestion of a single serving of reconstituted red wine. Am. J. Clin. Nutr. 71, 103–108.

    Article  CAS  Google Scholar 

  • Burr ML, Fehily AM, Butland BK, Bolton CH & Eastham RD (1986): Alcohol and high-desity-lipoprotein cholesterol: a randomized controlled trial. Br. J. Nutr. 56, 81–86.

    Article  CAS  Google Scholar 

  • Caccetta RA-A, Croft KD, Beilin LJ & Puddey IB (2000): Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am. J. Clin. Nutr. 71, 67–74.

    Article  CAS  Google Scholar 

  • Carbonneau M-A, Léger CL, Monnier L, Bonnet C, Michel F, Fouret G, Dedieu F & Descomps B (1997): Supplementation with wine phenolic compounds increases the antioxidant capacity of plasma and vitamin E of low-density lipoprotein without changing the lipoprotein Cu2+-oxidizability: possible explanation by phenolic location. Eur. J. Clin. Nutr. 51, 682–690.

    Article  CAS  Google Scholar 

  • Criqui MH & Ringel BL (1994): Does diet or alcohol explain the French paradox? Lancet 344, 1719–1923.

    Article  CAS  Google Scholar 

  • Day AP, Kemp HJ, Bolton C, Hartog M & Stansbie D (1997): Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation. Ann. Nutr. Metab. 41, 353–357.

    Article  CAS  Google Scholar 

  • de Rijke YB, Demacker PNM, Assen NA, Sloots LM, Katan MB & Stalenhoef AFH (1996): Red wine consumption does not affect oxidazability of low-density lipoproteins in volunteers. Am. J. Clin. Nutr. 63, 329–334.

    Article  CAS  Google Scholar 

  • Estruch R, Sacanella E, Badia E, Antunez E, Nicolas JM, Fernandez-Rotilio D, de Gaetano G, Rubin E & Urbano-Marquez A (2004): Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175, 117–123.

    Article  CAS  Google Scholar 

  • Frank T, Netzel M, Strass G, Bitsch R & Bitsch I (2003): Bioavailability of anthocyanidin-3-glucosides following consumption of red wine and red grape juice. Can. J. Physiol. Pharmacol. 81, 423–435.

    Article  CAS  Google Scholar 

  • Frankel EN, Kanner J, German JB, Parks E & Kinsella JE (1993): Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341, 454–457.

    Article  CAS  Google Scholar 

  • Goldberg DM, Garovic-Kocic V, Diamandis EP & Pace-Asciak CR (1996): Wine: does the colour count? Clin. Chim. Acta 246, 183–193.

    Article  CAS  Google Scholar 

  • Grønbæk M, Deis A, Sørensen TIA, Becker U, Schnohr P & Jensen G (1995): Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 310, 1165–1169.

    Article  Google Scholar 

  • Grønbæk M, Iversen L, Olsen J, Becker PU, Hardt F & Sørensen TIA (1997): Sensible drinking limits. Ugeskr. Læger 159, 5939–5945.

    PubMed  Google Scholar 

  • Grønbæk M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein HO, Jensen G & Sorensen TI (2000): Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann. Int. med. 133, 411–419.

    Article  Google Scholar 

  • Hankey CR, Lean ME, Lowe GD, Rumley A & Woodward M (2002): Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight pationts with angina pectoris. Eur. J. Clin. Nutr. 56, 1039–1045.

    Article  CAS  Google Scholar 

  • Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, Elis A & Aviram M (1997): Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17, 2744–2752.

    Article  CAS  Google Scholar 

  • Klatsky AL, Friedman GD, Siegelaub AB & Gerard MJ (1977): Alcohol consumption and blood pressure Kaiser-Permanente Multiphasic Health Examination data. N. Engl. J. Med. 296, 1194–1200.

    Article  CAS  Google Scholar 

  • Klatsky AL & Armstrong MA (1993): Alcoholic beverage choice and risk of coronaty artery disease mortality: do red wine drinkers fare best? Am. J. Cardiol. 71, 467–469.

    Article  CAS  Google Scholar 

  • Langer R, Criqui MH & Reed DM (1992): Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 85, 910–915.

    Article  CAS  Google Scholar 

  • Leger ASSt, Cochrane AL & Moore F (1979): Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1, 1017–1020.

    Article  Google Scholar 

  • Leighton F, Cuevas A, Guasch V, Perez DD, Strobel P, San Martin A, Urzua U, Diez MS, Foncea R, Castillo O, Mizon C, Espinoza MA, Urquiaga I, Rozowski J, Maiz A & Germain A (1999): Plasma polyphenols and antioxidants, oxidative DNA damage, endothelial function in a diet and wine intervention study in humans. Drugs Exp. Clin. Res. 25, 133–141.

    CAS  PubMed  Google Scholar 

  • Mennen LI, Balkau B, Vol S, Cacès E & Eschwège E (1999): A possible link between alcohol consumption and cardiovascular disease? Arterioscler. Thromb. Vasc. Biol. 19, 887–892.

    Article  CAS  Google Scholar 

  • Mezzano D, Leighton F, Martinez C, Marshall G, Cuevas A, Castillo O, Panes O, Munoz B, Perez DD, Mizon C, Rozowski J, San Martin A & Pereira J (2001): Complementary effects of mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. Eur. J. Clin. Nutr. 55, 444–451.

    Article  CAS  Google Scholar 

  • Miyagi Y, Miwa K & Inoue H (1997): Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am. J. Cardiol. 80, 1627–1631.

    Article  CAS  Google Scholar 

  • Pellegrini N, Pareti FI, Stabile F, Brusamolino A & Simonetti P (1996): Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur. J. Clin. Nutr. 50, 209–213.

    CAS  Google Scholar 

  • Pikaar NA, Wedel M, van der Beek EJ, van Dokkum W, Kempen HJ, Kluft C, Ockhuizen T & Hermus Rj (1987): Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism 36, 538–543.

    Article  CAS  Google Scholar 

  • Renaud S & de Lorgeril M (1992): Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523–1526.

    Article  CAS  Google Scholar 

  • Rimm EB, Klatsky A, Grobbee D & Stampfer MJ (1996): Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? BMJ 312, 731–736.

    Article  CAS  Google Scholar 

  • Rimm EB, Williams P, Fosher K, Criqui M & Stampfer MJ (1999): Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319, 1523–1528.

    Article  CAS  Google Scholar 

  • Royal College of Physicians (1987): A great and growing evil—the medical consequences of alcohol abuse. Report of a working party. London: Tavistoc.

  • Stein JH, Keevil JG, Wiebe DA, Aeschlimann S & Folts JD (1999): Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100, 1050–1055.

    Article  CAS  Google Scholar 

  • Theobald H, Bygren LO, Carstensen J & Engfeldt P (2000): A moderate intake of wine is associated with reduced total mortality and reduced mortality from cardiovascular disease. J. Stud. Alcohol 61, 652–656.

    Article  CAS  Google Scholar 

  • Tjønneland A, Grønbæk M, Stripp C & Overvad K (1999): Wine intake and diet in a random sample of 48763 Danish men and women. Am. J. Clin. Nutr. 69, 49–54.

    Article  Google Scholar 

  • Van der Gaag MS, Sierksma A, Schaafsma G, van Tol A, Geelhoed-Mieras T, Bakker M & Hendriks HF (2000): Moderate alcohol consumption and changes in postprandial lipoproteins of premenopausal and postmenopausal women: a diet-controlled, randomized intervention study. J. Womens Health Gend. Based Med. 9, 607–616.

    Article  CAS  Google Scholar 

  • Wannamethee SG & Shaper AG (1999): Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality. Am. J. Public Health 89, 685–690.

    Article  CAS  Google Scholar 

  • Wilkins J, Gallimore JR, Moore EG & Pepys MB (1998): Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin. Chem. 44, 1358–1361.

    CAS  PubMed  Google Scholar 

  • Williams PT (2004): The relationships of vigorous exercise, alcohol, and adiposity and high high-density lipoprotein-cholesterol levels. Metabolism 53, 700–709.

    Article  CAS  Google Scholar 

  • Young JF, Dragsted LO, Daneshvar B, Lauridsen ST, Hansen M & Sandström B (2000): The effect of grape-skin extract on oxidative status. Br. J. Nutr. 84, 505–513.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to M Grønbæk.

Additional information

Guarantors: P Marckmann and M Grønbæk.

Contributors: ASH, PM and MG initiated the formulation of the primary study hypothesis, discussed the core ideas, designed the protocol and wrote the paper. ASH collected and analysed all data. LOD, I-LFN and SEN discussed the core ideas, performed the biochemical analysis and edited the paper.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hansen, A., Marckmann, P., Dragsted, L. et al. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease. Eur J Clin Nutr 59, 449–455 (2005).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • intervention trial
  • red wine
  • high-density lipoprotein
  • cardiovascular disease
  • cholesterol
  • factor VII coagulant activity
  • body weight

This article is cited by


Quick links